2017 Symposium Schedule of Events

Sanford Consortium Auditorium, 2880 Torrey Pines Scenic Drive
 La Jolla, CA 92037; November 4 (Saturday), 2017

Conference Registration Conference Speakers Syllabus Download Directions to Sanford Consortium

Practical and Advanced Hematopathology
(With upto 6.75 CME Credits)

When:November 4 (Saturday), 2017
Where:Sanford Consortium Auditorium, 2880 Torrey Pines Scenic Drive
, La Jolla, CA 92037 (Directions)
Who should attend:Pathologists, Hematologists/Oncologists, and other professionals with an interest in hematopathology
Amenities:Continental Breakfast, Coffee breaks, Lunch, and Parking
Registration: Please visit the Registration Page.

Full Schedule for Saturday, November 4, 2017

7:20 AM - Onsite registration & continental breakfast

7:50 AMWelcome: Don Xu, MD, PhD UCSD/VAMC
8:00 AMKeynote lecture:
Practical Approach to Myelodysplasia: WHO 2016 and Beyond
Introduced by Dr. Frank Zhao, UCSD/VAMC

Kathryn Foucar, MD
Univ. New Mexico
9:30 AMLecture:
Lymphomas in the grey zone: a personal experience

Introduced by Don Xu, MD, PhD

Frank Zhao MD, PhD, MBA
UC San Diego/Phoenix VA

10:30 AM - Coffee Break

10:40 AMLecture:
Unique pediatric leukemia
Introduced by Richard Wong, MD, PhD

Jun Mo, MD
UC San Diego/Rady’s

11:40 AM - Lunch (for all attendees)
SDSH Business Meeting (SDSH members only)
Moderator: Dr. Huan-you Wang, UCSD
12:40 PMShort Sessions:
A Case Presentation of T cell Lymphoproliferative DisorderJessica Wang-Rodriguez, MD
VAMC/UC San Diego
An Unusual Case of Cutaneous T cell Lymphoma Richard Wong, MD PhD
UC San Diego
Starting Early: A WHO 2016 New Leukemia DesignationSteve Gauerke, MD
Naval Medical Center
Mycosis Fungoides, Lymphomatoid Papulosis, or Both?Qinghong Yang, MD, PhD
VAMC/UC San Diego

2:40 PM - Coffee Break

Moderator: Beth Broome, MD, PhD; UCSD
2:50 PMShort Talk:
Immunoshifting in Hepatosplenic T cell Lymphoma After Chemotherapy

Don Xu, MD PhD
3:20 PMLecture:
Diagnosis and Differential Diagnosis of Selected 2016 WHO Provisional Entities

Huan-you Wang, MD, PhD
UC San Diego

4:10 PM - Adjourn


Our Organizing Committee:

H. Elizabeth Broome, MD, Professor & Director, Hematology Lab, CALM of UCSD
Arash Mohtashamian, MD, CDR MC USN, Staff Hematopathologist & Residency Program Director, Naval Medical Center
Robert Sharpe, MD,, Professor & Senior Staff Hematopathologist, UCSD/Scripps Green Hospital
Huan-You Wang, MD, PhD, Professor & Director, Hematopathology Fellowship, UCSD
Jessica Wang-Rodriguez, MD, Professor & Chief, PALMS, UCSD/VAMC
Xiangdong (Don) Xu, MD, PhD, Associate Professor, UCSD/VAMC
Qinghong Yang, MD, PhD, Associate Professor, UCSD/VAMC
Frank Zhao, MD, PhD, MBA, Professor & Chief, Hematopathology, UCSD/VAMC (Program Director)

The University of California, San Diego School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The University of California, San Diego School of Medicine designates this live activity for a maximum of 7.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

It is the policy of the University of California, San Diego School of Medicine to ensure balance, independence, objectivity and scientific rigor. All persons involved in the selection, development and presentation of content are required to disclose any real or apparent conflicts of interest. All conflicts of interest will be resolved prior to an educational activity being delivered to learners through one of the following mechanisms 1) altering the financial relationship with the commercial interest, 2) altering the individual’s control over CME content about the products or services of the commercial interest, and/or 3) validating the activity content through independent peer review. All persons are also required to disclose any discussions of off label/unapproved uses of drugs or devices. Persons who refuse or fail to disclose will be disqualified from participating in the CME activity.

This activity is in compliance with California Assembly Bill 1195 which requires continuing medical education activities with patient care components to include curriculum in the subjects of cultural and linguistic competency. Cultural competency is defined as a set of integrated attitudes, knowledge, and skills that enables health care professionals or organizations to care effectively for patients from diverse cultures, groups, and communities. Linguistic competency is defined as the ability of a physician or surgeon to provide patients who do not speak English or who have limited ability to speak English, direct communication in the patient’s primary language. Cultural and linguistic competency was incorporated into the planning of this activity. Additional resources on cultural and linguistic competency and information about AB1195 can be found on the UCSD CME website at http://cme.ucsd.edu